253 related articles for article (PubMed ID: 15476157)
61. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
62. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).
Burra P; Senzolo M; Adam R; Delvart V; Karam V; Germani G; Neuberger J; ;
Am J Transplant; 2010 Jan; 10(1):138-48. PubMed ID: 19951276
[TBL] [Abstract][Full Text] [Related]
63. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
64. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes.
Shen NT; Londono C; Gold S; Wu A; Mages KC; Brown RSJ
World J Gastroenterol; 2019 Apr; 25(13):1628-1639. PubMed ID: 30983822
[TBL] [Abstract][Full Text] [Related]
65. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
66. Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?
Wieland A; Everson GT
Alcohol Alcohol; 2018 Mar; 53(2):187-192. PubMed ID: 29329373
[TBL] [Abstract][Full Text] [Related]
67. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
[TBL] [Abstract][Full Text] [Related]
68. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA.
Cholankeril G; Goli K; Rana A; Hernaez R; Podboy A; Jalal P; Da BL; Satapathy SK; Kim D; Ahmed A; Goss J; Kanwal F
Hepatology; 2021 Dec; 74(6):3316-3329. PubMed ID: 34310738
[TBL] [Abstract][Full Text] [Related]
69. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
Kwong AJ; Kim WR; Flemming JA
Hepatology; 2018 Oct; 68(4):1288-1297. PubMed ID: 29672886
[TBL] [Abstract][Full Text] [Related]
70. Trends in mortality in hepatitis C infection and alcoholic liver disease based on drug overdose in the United States.
Kim D; Alshuwaykh OS; Cholankeril G; Wong RJ; Ahmed A
J Viral Hepat; 2021 Feb; 28(2):436-439. PubMed ID: 33147365
[TBL] [Abstract][Full Text] [Related]
71. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
72. Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C.
Ampuero J; Jimeno C; Quiles R; Rosales JM; Llerena S; Palomo N; Cordero P; Serrano FJ; Urquijo JJ; Moreno-Planas JM; Ontanilla G; Hernández M; Ortega-Alonso A; Maraver M; Bonacci M; Rojas Á; Figueruela B; Forns X; Andrade RJ; Calleja JL; Diago M; Carmona I; de la Mata M; Buti M; Crespo J; Pascasio JM; Navarro JM; Salmerón J; Romero-Gómez M
J Hepatol; 2018 May; 68(5):940-948. PubMed ID: 29288753
[TBL] [Abstract][Full Text] [Related]
73. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
74. Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis.
Ikeda K; Kobayashi M; Someya T; Saitoh S; Tsubota A; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
Intervirology; 2002; 45(2):71-8. PubMed ID: 12145538
[TBL] [Abstract][Full Text] [Related]
75. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Bucci L; Garuti F; Camelli V; Lenzi B; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Maida M; Felder M; Morisco F; Gasbarrini A; Gemini S; Foschi FG; Missale G; Masotto A; Affronti A; Bernardi M; Trevisani F; ;
Aliment Pharmacol Ther; 2016 Feb; 43(3):385-99. PubMed ID: 26662476
[TBL] [Abstract][Full Text] [Related]
76. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
[TBL] [Abstract][Full Text] [Related]
77. Liver transplantation for alcoholic liver disease.
Lucey MR
Nat Rev Gastroenterol Hepatol; 2014 May; 11(5):300-7. PubMed ID: 24393837
[TBL] [Abstract][Full Text] [Related]
78. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
79. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
80. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
